Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

PHASE4UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

June 30, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

insulin aspart and detemir (NovoRapid, Levemir)

use of basal-bolus therapy with insulin aspart and detemir

DRUG

human regular insulin and NPH insulin (Actrapid, Protaphne)

basal-bolus therapy with human regular and NPH insulin

Trial Locations (1)

81925

Staedt. Klinikum Muenchen Bogenhausen, Munich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Munich Municipal Hospital

OTHER

NCT00747409 - Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes | Biotech Hunter | Biotech Hunter